SAI MedPartners Acquires PharmaForce International

SAI MedPartners Acquires IDEA Pharma

November 14, 2024

Healthcare Services

SAI MedPartners, a global life-sciences consultancy backed by Northlane Capital Partners, has acquired London-headquartered IDEA Pharma to strengthen its pharmaceutical path-to-market, clinical development, and commercialization capabilities. The acquisition is an add-on to SAI's platform, expanding its strategic services offering to biopharma and medical device clients.

Northlane Capital Partners Invests in SAI MedPartners

June 7, 2022

Healthcare Services

Northlane Capital Partners has made an investment in SAI MedPartners, a life-sciences consultancy providing competitive intelligence, strategy, and analytics to pharmaceutical, biotechnology, and medical device companies. The investment, made in partnership with SAI management led by Founder and CEO Erik Nordhoy, will support expansion of SAI's service offerings and global growth. SAI is headquartered in Reading, Pennsylvania and has more than 180 employees across the United States, Europe, and Asia.

Eir Partners Majority Recapitalizes PharmaForceIQ

September 10, 2024

Cloud & SaaS

Eir Partners completed a majority recapitalization of PharmaForceIQ (PFIQ), an AI-driven omnichannel orchestration and measurement platform for pharmaceutical and life science companies. The investment will fund product development, key hires and continued accumulation of data assets to scale PFIQ's HCP and DTC omnichannel offerings.

SAI MedPartners Acquires Fulcrum Research Group

January 4, 2023

Healthcare Services

SAI MedPartners, a consultancy backed by Northlane Capital Partners, has acquired Fulcrum Research Group, a Waltham, MA-based primary market research firm focused on healthcare and biopharma. The add-on expands SAI's strategic insights and primary research capabilities to better serve pharmaceutical, biotechnology, and medical device clients.

Aquiline Makes Majority Investment in Pharma Force Group LLC

December 31, 2023

Healthcare Services

Aquiline Capital Partners has made a majority investment in Pharma Force Group LLC, a U.S.-based provider of 340B administration software and pharmacy benefits management solutions. The partnership will support PharmaForce’s product expansion and strategic M&A plans to accelerate growth across hospitals and health clinics. Piper Sandler advised PharmaForce; transaction closed in Q4 2023 with financial terms undisclosed.

Enhanced Healthcare Partners & Bourne Partners Strategic Capital Acquire Pharmaceutical Associates, Inc.

November 6, 2019

Pharmaceuticals

Enhanced Healthcare Partners (EHP), together with Bourne Partners Strategic Capital (BPSC), announced the acquisition of Pharmaceutical Associates, Inc. (PAI), a U.S. manufacturer of generic liquid and unit-dose pharmaceuticals. The investment will provide growth capital to expand PAI's manufacturing capacity, product lines and market footprint while leveraging BPSC's pharmaceutical network and EHP's healthcare investment experience.